2-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl]-4-phenyl-[1]benzothiolo[3,2-d]pyrimidine
C37H22FN5S — CID 147727859
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl]-4-phenyl-[1]benzothiolo[3,2-d]pyrimidine
2-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl]-4-phenyl-[1]benzothiolo[3,2-d]pyrimidine (PubChem CID 147727859) has the molecular formula C37H22FN5S and a molecular weight of 587.68 g/mol. Its IUPAC name is 2-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl]-4-phenyl-[1]benzothiolo[3,2-d]pyrimidine.
Molecular Properties
| Compound Name | 2-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl]-4-phenyl-[1]benzothiolo[3,2-d]pyrimidine |
|---|---|
| PubChem CID | 147727859 |
| Molecular Formula | C37H22FN5S |
| Molecular Weight | 587.68 g/mol |
| Exact Mass | 587.16 |
| IUPAC Name | 2-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-2-fluorophenyl]-4-phenyl-[1]benzothiolo[3,2-d]pyrimidine |
| SMILES | Fc1ccc(-c2nc(-c3ccccc3)nc(-c3ccccc3)n2)cc1-c1nc(-c2ccccc2)c2sc3ccccc3c2n1 |
| InChI | InChI=1S/C37H22FN5S/c38-29-21-20-26(36-42-34(24-14-6-2-7-15-24)41-35(43-36)25-16-8-3-9-17-25)22-28(29)37-39-31(23-12-4-1-5-13-23)33-32(40-37)27-18-10-11-19-30(27)44-33/h1-22H |
| InChIKey | GXVMMHLQHGGAGZ-UHFFFAOYSA-N |
| XLogP | 9.50 |
| TPSA | 64.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 587.68 |
| LogP ≤ 5 | 9.50 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147727859 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.